Cleared Traditional

K150971 - Zekang Self-adhesive Electrode

K150971 is an FDA 510(k) clearance for Zekang Self-adhesive Electrode, manufactured by Jiangsu Zekang Medical Technology Co., Ltd.. The device is a Class 2 Neurology device with product code GXY cleared through the Traditional 510(k) pathway after a 134-day FDA review.

K150971 · Jiangsu Zekang Medical Technology Co., Ltd. · Neurology device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Aug 2015
Decision
134d
Days
Class 2
Risk

K150971 is an FDA 510(k) clearance for the Zekang Self-adhesive Electrode. Classified as Electrode, Cutaneous (product code GXY), Class II - Special Controls.

Submitted by Jiangsu Zekang Medical Technology Co., Ltd. (Wuxi, CN). The FDA issued a Cleared decision on August 25, 2015 after a review of 134 days - within the typical 510(k) review window.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1320 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K150971

510(k) Number K150971 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 13, 2015
Decision Date August 25, 2015
Days to Decision 134 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
15d faster than avg
Panel avg: 149d · This submission: 134d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GXY Device Classification - Class 2, Special Controls

Product Code GXY Electrode, Cutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1320
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Consultant

Shanghai CV Technology Co., Ltd.
Doris Dong

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - GXY Electrode, Cutaneous

All 358
Devices cleared under the same product code (GXY) and FDA review panel - the closest regulatory comparables to K150971.
Ennova Self-adhesive Electrode
K152648 · Suzhou Ennova Electronics Technology Co.,Ltd · Feb 2016
Dr-Ho's Foot Pad Electrode
K151693 · Drtv Asia, Ltd. · Oct 2015
Neon EEG
K151576 · Incereb, Ltd. · Sep 2015
Philips Self-Adhesive Electrodes
K151033 · Philips Consumer Lifestyle · Jul 2015
DISPOSABLE PRE-GELLED SURFACE ELECTRODE
K142159 · Rochester Electro Medical, Inc. · Jun 2015
BIS STANDARD SENSOR,1-CHANNEL (3 ELECTRODES)
K143506 · Covidien · Apr 2015